These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 12836271)
21. Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis. Ravikumar VT; Capaldi DC; Lima WF; Lesnik E; Turney B; Cole DL Bioorg Med Chem; 2003 Oct; 11(21):4673-9. PubMed ID: 14527564 [TBL] [Abstract][Full Text] [Related]
22. Best minimally modified antisense oligonucleotides according to cell nuclease activity. Samani TD; Jolles B; Laigle A Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):129-36. PubMed ID: 11446588 [TBL] [Abstract][Full Text] [Related]
23. A cytosine analog that confers enhanced potency to antisense oligonucleotides. Flanagan WM; Wolf JJ; Olson P; Grant D; Lin KY; Wagner RW; Matteucci MD Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3513-8. PubMed ID: 10097067 [TBL] [Abstract][Full Text] [Related]
24. Investigation of antisense DNA having C-5 polyamine substituted 2'-deoxyuridine derivative. Sakai H; Moriguchi T; Suzuki H; Matsukura M; Shinozuka K Nucleic Acids Res Suppl; 2001; (1):127-8. PubMed ID: 12836297 [TBL] [Abstract][Full Text] [Related]